Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2025 Earnings Call Transcript November 14, 2025
Iterum Therapeutics plc misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.13.
Operator: Hello, and welcome everyone to the Iterum Therapeutics Third Quarter 2025 Financial Results. My name is Becky, and I will be your operator today. All lines will be muted throughout the presentation portion of the call. I will now hand over to your host, Kevin Dalton, Senior Director of...
